Somnus

Active
No
Status
Posted
Published Date
April 29th, 2024
Close Date
June 17th, 2024
Opportunity No.
DARPARA2402

Agency

DARPA - Biological Technologies Office (DOD-DARPA-BTO)

Eligible Applicants

Others

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Other

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The federal grant notice titled "Somnus" is being offered by the DARPA - Biological Technologies Office. The grant falls under the category of Science and Technology and other Research and Development. The opportunity is currently open and falls under the discretionary funding category. The purpose of this grant is to support research on the identification of molecules and mechanisms of host interactions with the gut microbiome that are associated with the restorative effect of sleep on cognitive performance. The DARPA's Biological Technologies Office (BTO) is seeking rapid, targeted, and limited scope investments through this Research Announcement. The grant does not require cost sharing or matching. It is open to all responsible sources capable of satisfying the government's needs. The eligibility information can be found in the BAA (Broad Agency Announcement) for more details. The opportunity will close on June 17, 2024. Interested applicants can find additional information and submit proposals through the SAM.gov Contract Opportunities website. For any inquiries, contact Matthew Pava at Somnus@darpa.mil. Please ensure the summary is centered around the research thrust of "Somnus," which focuses on the identification of molecules and mechanisms associated with the restorative effect of sleep on cognitive performance.

Description

This Research Announcement represents a Solicitation for a research thrust, entitled Somnus, that will focus on the identification of molecules and mechanisms of host interactions with the gut microbiome that are associated with the restorative effect of sleep on cognitive performance. DARPA’s Biological Technologies Office (BTO) solicits rapid, targeted and limited scope investments through our Research Announcements. A Research Announcement enables DARPA to initiate a new investment in less than 120 calendar days after the proposal submission window for this RA closes.

Contact Information

Attachments
418 KB
368 KB
118 KB

Opportunity Lifecycle

Title
Type
Grant